Saltar al contenido
Merck

Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-04-18)
Hao-wei Shen, Michael D Scofield, Heather Boger, Megan Hensley, Peter W Kalivas
RESUMEN

Reducing the enduring vulnerability to relapse is a therapeutic goal in treating drug addiction. Studies with animal models of drug addiction show a marked increase in extrasynaptic glutamate in the core subcompartment of the nucleus accumbens (NAcore) during reinstated drug seeking. However, the synaptic mechanisms linking drug-induced changes in extrasynaptic glutamate to relapse are poorly understood. Here, we discovered impaired glutamate elimination in rats extinguished from heroin self-administration that leads to spillover of synaptically released glutamate into the nonsynaptic extracellular space in NAcore and investigated whether restoration of glutamate transport prevented reinstated heroin seeking. Through multiple functional assays of glutamate uptake and analyzing NMDA receptor-mediated currents, we show that heroin self-administration produced long-lasting downregulation of glutamate uptake and surface expression of the transporter GLT-1. This downregulation was associated with spillover of synaptic glutamate to extrasynaptic NMDA receptors within the NAcore. Ceftriaxone restored glutamate uptake and prevented synaptic glutamate spillover and cue-induced heroin seeking. Ceftriaxone-induced inhibition of reinstated heroin seeking was blocked by morpholino-antisense targeting GLT-1 synthesis. These data reveal that the synaptic glutamate spillover in the NAcore results from reduced glutamate transport and is a critical pathophysiological mechanism underling reinstated drug seeking in rats extinguished from heroin self-administration.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Ácido L-aspártico, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
Sigma-Aldrich
Ácido L-aspártico, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Glutamic acid, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Ácido L-aspártico, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
Ceftriaxone disodium salt hemi(heptahydrate), third-generation cephalosporin antibiotic
Sigma-Aldrich
D-Glutamic acid, ≥99% (TLC)
Sigma-Aldrich
L-Aspartic acid potassium salt, ≥98% (HPLC)
Sigma-Aldrich
Ácido L-aspártico, BioUltra, ≥99.5% (T)
Sigma-Aldrich
DL-Aspartic acid, ≥99% (TLC)
Sigma-Aldrich
L-Glutamic acid hydrochloride
Sigma-Aldrich
L-Glutamic acid, FCC
SAFC
Ácido L-aspártico
USP
Ceftriaxone sodium, United States Pharmacopeia (USP) Reference Standard
Supelco
Ceftriaxone Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
Ácido L-aspártico, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Glutamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ácido L-aspártico, Pharmaceutical Secondary Standard; Certified Reference Material
Glutamic acid, European Pharmacopoeia (EP) Reference Standard
Ceftriaxone sodium, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Glutamic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Ácido L-aspártico, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland